Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

LLY – Eli Lilly and Company

Eli Lilly and Company
LLY
$762.33
Name : Eli Lilly and Company
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $684,371,083,264.00
EPSttm : 12.27
finviz dynamic chart for LLY
Eli Lilly and Company
$762.33
3.01%
$22.26

Float Short %

0.9

Margin Of Safety %

Put/Call OI Ratio

0.85

EPS Next Q Diff

2.79

EPS Last/This Y

10.2

EPS This/Next Y

7.96

Price

762.33

Target Price

989

Analyst Recom

1.53

Performance Q

-4

Relative Volume

1.26

Beta

0.44

Ticker: LLY




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04LLY7790.710.83370916
2025-07-07LLY772.470.710.10355358
2025-07-08LLY777.660.690.80374642
2025-07-09LLY786.540.690.61380522
2025-07-10LLY790.240.680.66391576
2025-07-11LLY792.780.690.63398097
2025-07-14LLY799.150.700.68379473
2025-07-15LLY771.50.700.54386980
2025-07-16LLY789.490.670.81414882
2025-07-17LLY762.080.680.75422843
2025-07-18LLY771.930.670.69437219
2025-07-21LLY762.410.781.16348100
2025-07-22LLY775.430.790.68361024
2025-07-23LLY799.070.790.67367902
2025-07-24LLY8040.760.52383028
2025-07-25LLY811.750.760.46394720
2025-07-28LLY806.590.750.39370031
2025-07-29LLY7640.820.61360786
2025-07-30LLY757.770.800.47388679
2025-07-31LLY739.670.780.53402152
2025-08-01LLY762.540.850.85394038
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04LLY780.6741.99585.621.79
2025-07-07LLY772.6941.99311.421.79
2025-07-08LLY777.6641.99686.321.79
2025-07-09LLY786.9241.99816.821.79
2025-07-10LLY790.6541.99653.221.79
2025-07-11LLY793.0141.99721.721.79
2025-07-14LLY799.1941.99723.021.79
2025-07-15LLY771.7541.98755.721.79
2025-07-16LLY789.7741.910077.921.79
2025-07-17LLY761.5041.98726.121.79
2025-07-18LLY771.7941.99853.121.79
2025-07-21LLY762.4341.99270.421.79
2025-07-22LLY776.2441.99965.721.79
2025-07-23LLY798.8941.910205.121.79
2025-07-24LLY805.4341.79732.121.88
2025-07-25LLY812.6941.710031.521.88
2025-07-28LLY807.1442.59664.821.96
2025-07-29LLY762.9542.58529.621.96
2025-07-30LLY760.0842.59736.021.96
2025-07-31LLY740.0742.59215.421.96
2025-08-01LLY762.3342.610516.021.96
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04LLY-0.890.770.94
2025-07-07LLY-0.890.770.94
2025-07-08LLY-0.890.770.94
2025-07-09LLY-0.890.770.94
2025-07-10LLY-0.890.770.94
2025-07-11LLY-0.890.770.91
2025-07-14LLY-0.890.990.91
2025-07-15LLY-0.890.990.91
2025-07-16LLY-0.890.990.91
2025-07-17LLY-0.890.990.91
2025-07-18LLY-0.890.990.91
2025-07-21LLY-0.891.200.91
2025-07-22LLY-0.891.200.91
2025-07-23LLY-0.891.200.91
2025-07-24LLY-0.891.200.91
2025-07-25LLY-1.171.200.90
2025-07-28LLY-1.170.670.90
2025-07-29LLY-1.180.670.90
2025-07-30LLY-1.180.670.90
2025-07-31LLY-1.180.670.90
2025-08-01LLY-1.180.670.90
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

3.34

Avg. EPS Est. Current Quarter

5.56

Avg. EPS Est. Next Quarter

6.13

Insider Transactions

-1.18

Institutional Transactions

0.67

Beta

0.44

Average Sales Estimate Current Quarter

14401

Average Sales Estimate Next Quarter

15482

Fair Value

Quality Score

95

Growth Score

100

Sentiment Score

9

Actual DrawDown %

21.6

Max Drawdown 5-Year %

-25.3

Target Price

989

P/E

63.15

Forward P/E

25.38

PEG

1.49

P/S

14.74

P/B

45.85

P/Free Cash Flow

193.36

EPS

12.07

Average EPS Est. Cur. Y​

21.96

EPS Next Y. (Est.)

29.92

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

22.66

Relative Volume

1.26

Return on Equity vs Sector %

46.7

Return on Equity vs Industry %

38.5

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.17

EBIT Estimation

10516
Eli Lilly and Company
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 47000
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of cancer; and Chugai Pharmaceutical Co., Ltd, as well as Strategic Collaboration with Eli Lilly to advance development of its myeloid engager platform for autoimmune disease. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
stock quote shares LLY – Eli Lilly and Company Stock Price stock today
news today LLY – Eli Lilly and Company stock forecast ,stock prediction 2023 2024 2025
marketwatch LLY – Eli Lilly and Company yahoo finance google finance
stock history LLY – Eli Lilly and Company invest stock market
stock prices LLY premarket after hours
ticker LLY fair value insiders trading